Press

More Cancer Mutations, Better Immunotherapy Outcomes

Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn’t true for all cancers.

Considering Genomic Research?
*
 
*
*
 


2019 © MedGenome • All Rights Reserved